Onset and pre-onset studies to define the Huntington’s disease natural history
Identifieur interne : 003193 ( Main/Curation ); précédent : 003192; suivant : 003194Onset and pre-onset studies to define the Huntington’s disease natural history
Auteurs : F. Squitieri [Italie] ; M. Cannella [Italie] ; P. Giallonardo [Italie] ; V. Maglione [Italie] ; C. Mariotti [Italie] ; M. R. Hayden [Canada]Source :
- Brain Research Bulletin [ 0361-9230 ] ; 2001.
English descriptors
Abstract
Huntington’s disease’s (HD) clinical history has not been defined yet. However, many aspects of the most confusing clinical stages, i.e., the first and last disease phases, including the symptom progression and the disease duration, have been better approached after discovery of the responsible gene. The existence of accurate genetic tests, available for affected and pre-symptomatic subjects (i.e., mutation carriers) and the possibility to study transgenic in vivo models, are actually helping us to understand some of the aspects of HD clinical presentation. HD may present with motor symptoms other than chorea, the psychiatric manifestations may represent part of the clinical picture and cognitive deterioration may occur very early in the disease and depend on early cortical involvement. Pre-onset studies are of crucial importance in understanding the temporal sequence of the clinical events. This is also very important for future therapeutic strategies in those diseases initiating late in the life, such as HD.
Url:
DOI: 10.1016/S0361-9230(01)00648-7
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002A25
- to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :002A25
- to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001021
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :003674
Links to Exploration step
ISTEX:15F32D0387E2F0031C413C67C5CE17E6434C7AA5Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Onset and pre-onset studies to define the Huntington’s disease natural history</title><author><name sortKey="Squitieri, F" sort="Squitieri, F" uniqKey="Squitieri F" first="F." last="Squitieri">F. Squitieri</name></author><author><name sortKey="Cannella, M" sort="Cannella, M" uniqKey="Cannella M" first="M." last="Cannella">M. Cannella</name></author><author><name sortKey="Giallonardo, P" sort="Giallonardo, P" uniqKey="Giallonardo P" first="P." last="Giallonardo">P. Giallonardo</name></author><author><name sortKey="Maglione, V" sort="Maglione, V" uniqKey="Maglione V" first="V." last="Maglione">V. Maglione</name></author><author><name sortKey="Mariotti, C" sort="Mariotti, C" uniqKey="Mariotti C" first="C." last="Mariotti">C. Mariotti</name></author><author><name sortKey="Hayden, M R" sort="Hayden, M R" uniqKey="Hayden M" first="M. R." last="Hayden">M. R. Hayden</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:15F32D0387E2F0031C413C67C5CE17E6434C7AA5</idno><date when="2001" year="2001">2001</date><idno type="doi">10.1016/S0361-9230(01)00648-7</idno><idno type="url">https://api-v5.istex.fr/document/15F32D0387E2F0031C413C67C5CE17E6434C7AA5/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002A25</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002A25</idno><idno type="wicri:Area/Istex/Curation">002A25</idno><idno type="wicri:Area/Istex/Checkpoint">001021</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001021</idno><idno type="wicri:doubleKey">0361-9230:2001:Squitieri F:onset:and:pre</idno><idno type="wicri:Area/Main/Merge">003674</idno><idno type="wicri:Area/Main/Curation">003193</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Onset and pre-onset studies to define the Huntington’s disease natural history</title><author><name sortKey="Squitieri, F" sort="Squitieri, F" uniqKey="Squitieri F" first="F." last="Squitieri">F. Squitieri</name><affiliation wicri:level="1"><country wicri:rule="url">Italie</country></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Neurogenetics Unit, Neurological Institute IRCCS “Neuromed”, Pozzilli (IS)</wicri:regionArea><wicri:noRegion>Pozzilli (IS)</wicri:noRegion></affiliation></author><author><name sortKey="Cannella, M" sort="Cannella, M" uniqKey="Cannella M" first="M." last="Cannella">M. Cannella</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Neurogenetics Unit, Neurological Institute IRCCS “Neuromed”, Pozzilli (IS)</wicri:regionArea><wicri:noRegion>Pozzilli (IS)</wicri:noRegion></affiliation></author><author><name sortKey="Giallonardo, P" sort="Giallonardo, P" uniqKey="Giallonardo P" first="P." last="Giallonardo">P. Giallonardo</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Neurogenetics Unit, Neurological Institute IRCCS “Neuromed”, Pozzilli (IS)</wicri:regionArea><wicri:noRegion>Pozzilli (IS)</wicri:noRegion></affiliation></author><author><name sortKey="Maglione, V" sort="Maglione, V" uniqKey="Maglione V" first="V." last="Maglione">V. Maglione</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Neurogenetics Unit, Neurological Institute IRCCS “Neuromed”, Pozzilli (IS)</wicri:regionArea><wicri:noRegion>Pozzilli (IS)</wicri:noRegion></affiliation></author><author><name sortKey="Mariotti, C" sort="Mariotti, C" uniqKey="Mariotti C" first="C." last="Mariotti">C. Mariotti</name><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Division of Biochemistry and Genetics, Neurological Institute “C. Besta”, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author><author><name sortKey="Hayden, M R" sort="Hayden, M R" uniqKey="Hayden M" first="M. R." last="Hayden">M. R. Hayden</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia</wicri:regionArea><wicri:noRegion>British Columbia</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Brain Research Bulletin</title><title level="j" type="abbrev">BRB</title><idno type="ISSN">0361-9230</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="2001">2001</date><biblScope unit="volume">56</biblScope><biblScope unit="issue">3–4</biblScope><biblScope unit="page" from="233">233</biblScope><biblScope unit="page" to="238">238</biblScope></imprint><idno type="ISSN">0361-9230</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0361-9230</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Clinical history</term><term>Onset symptoms</term><term>Predictive diagnosis</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Huntington’s disease’s (HD) clinical history has not been defined yet. However, many aspects of the most confusing clinical stages, i.e., the first and last disease phases, including the symptom progression and the disease duration, have been better approached after discovery of the responsible gene. The existence of accurate genetic tests, available for affected and pre-symptomatic subjects (i.e., mutation carriers) and the possibility to study transgenic in vivo models, are actually helping us to understand some of the aspects of HD clinical presentation. HD may present with motor symptoms other than chorea, the psychiatric manifestations may represent part of the clinical picture and cognitive deterioration may occur very early in the disease and depend on early cortical involvement. Pre-onset studies are of crucial importance in understanding the temporal sequence of the clinical events. This is also very important for future therapeutic strategies in those diseases initiating late in the life, such as HD.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003193 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 003193 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Curation
|type= RBID
|clé= ISTEX:15F32D0387E2F0031C413C67C5CE17E6434C7AA5
|texte= Onset and pre-onset studies to define the Huntington’s disease natural history
}}
| This area was generated with Dilib version V0.6.29. |  |